Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Lonergan, Kim M ^a   Chari, Raj ^a   Coe, Bradley P ^a   Wilson, Ian M ^a   Tsao, Ming Sound ^b   Ng, Raymond T ^a,c   MacAulay, Calum ^a   Lam, Stephen ^a   Lam, Wan L ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CANCER INVASION; CARCINOMA IN SITU; CILIARY MOTILITY; CLINICAL ARTICLE; COMPARATIVE STUDY; DETOXIFICATION; DISEASE COURSE; EPIDERMIS; FEMALE; GENE EXPRESSION PROFILING; GENE NUMBER; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LUNG NON SMALL CELL CANCER; MALE; PHENOTYPE; PRECANCER; SERIAL ANALYSIS OF GENE EXPRESSION; SQUAMOUS CELL CARCINOMA; XENOBIOTIC METABOLISM; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; LUNG; LUNG TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77949382936     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009162     Document Type: Article

References (149)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Auberger J, Loeffler-Ragg J, Wurzer W, Hilbe W (2006) Targeted therapies in non-small cell lung cancer: proven concepts and unfulfilled promises. Curr Cancer Drug Targets 6: 271-294.
3. Di Maio M, Gridelli C, Normanno N, Perrone F, Ciardiello F (2005) Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. J Cell Physiol 205: 355-363.
4. Isobe T, Herbst RS, Onn A (2005) Current management of advanced nonsmall cell lung cancer: targeted therapy. Semin Oncol 32: 315-328.
5. Janne PA, Johnson BE (2006) Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors. Clin Cancer Res 12: 4416s-4420s.
6. Maione P, Gridelli C, Troiani T, Ciardiello F (2006) Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC. Oncologist 11: 274-284.
7. Gazdar AF, Miyajima K, Reddy J, Sathyanarayana UG, Shigematsu H, et al. (2004) Molecular targets for cancer therapy and prevention. Chest 125: 97S-101S.
8. Mazieres J, He B, You L, Xu Z, Jablons DM (2005) Wnt signaling in lung cancer. Cancer Lett 222: 1-10.
9. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y (2001) The new World Health Organization classification of lung tumours. Eur Respir J 18: 1059-1068.
10. Garnis C, Davies JJ, Buys TP, Tsao MS, MacAulay C, et al. (2005) Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression. Oncogene 24: 4806-4812.
11. Kerr KM (2001) Pulmonary preinvasive neoplasia. J Clin Pathol 54: 257-271.
12. Wistuba, II, Gazdar AF (2006) Lung cancer preneoplasia. Annu Rev Pathol 1: 331-348.
13. Lam S, Kennedy T, Unger M, Miller YE, Gelmont D, et al. (1998) Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 113: 696-702.
14. Lam S, MacAulay C, leRiche JC, Palcic B (2000) Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer 89: 2468-2473.
15. Hofmann HS, Bartling B, Simm A, Murray R, Aziz N, et al. (2006) Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array. Oncol Rep 16: 587-595.
16. Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, et al. (2006) Smoking and cancer-related gene expression in bronchial epithelium and nonsmall-cell lung cancers. J Pathol 210: 192-204.
17. Tanney A, Oliver GR, Farztdinov V, Kennedy RD, Mulligan JM, et al. (2008) Generation of a non-small cell lung cancer transcriptome microarray. BMC Med Genomics 1: 20.
18. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW (1995) Serial analysis of gene expression. Science 270: 484-487.
19. Lonergan KM, Chari R, Deleeuw RJ, Shadeo A, Chi B, et al. (2006) Identification of novel lung genes in bronchial epithelium by serial analysis of gene expression. Am J Respir Cell Mol Biol 35: 651-661.
20. Sturn A, Quackenbush J, Trajanoski Z (2002) Genesis: cluster analysis of microarray data. Bioinformatics 18: 207-208.
21. Boon K, Osorio EC, Greenhut SF, Schaefer CF, Shoemaker J, et al. (2002) An anatomy of normal and malignant gene expression. Proc Natl Acad Sci U S A 99: 11287-11292.
22. Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL (2005) Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65: 7561-7567.
23. Ishkanian AS, Malloff CA, Watson SK, DeLeeuw RJ, Chi B, et al. (2004) A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 36: 299-303.
24. Watson SK, deLeeuw RJ, Horsman DE, Squire JA, Lam WL (2007) Cytogenetically balanced translocations are associated with focal copy number alterations. Hum Genet 120: 795-805.
25. Aviel-Ronen S, Coe BP, Lau SK, da Cunha Santos G, Zhu CQ, et al. (2008) Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features. Proc Natl Acad Sci U S A 105: 10155-10160.
26. Ishkanian AS, Mallof CA, Ho J, Meng A, Albert M, et al. (2009) Highresolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer. Prostate 69: 1091-1100.
27. Buys TP, Aviel-Ronen S, Waddell TK, Lam WL, Tsao MS (2009) Defining genomic alteration boundaries for a combined small cell and non-small cell lung carcinoma. J Thorac Oncol 4: 227-239.
28. Garnis C, Chari R, Buys TP, Zhang L, Ng RT, et al. (2009) Genomic imbalances in precancerous tissues signal oral cancer risk. Mol Cancer 8: 50.
29. Deleeuw RJ, Zettl A, Klinker E, Haralambieva E, Trottier M, et al. (2007) Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 132: 1902-1911.
30. Mastracci TL, Shadeo A, Colby SM, Tuck AB, O'Malley FP, et al. (2006) Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast. Genes Chromosomes Cancer 45: 1007-1017.
31. Khojasteh M, Lam WL, Ward RK, MacAulay C (2005) A stepwise framework for the normalization of array CGH data. BMC Bioinformatics 6: 274.
32. Jong K, Marchiori E, Meijer G, Vaart AV, Ylstra B (2004) Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics 20: 3636-3637.
33. Chari R, Lockwood WW, Coe BP, Chu A, Macey D, et al. (2006) SIGMA: a system for integrative genomic microarray analysis of cancer genomes. BMC Genomics 7: 324.
34. Chari R, Coe BP, Wedseltoft C, Benetti M, Wilson IM, et al. (2008) SIGMA2: a system for the integrative genomic multi-dimensional analysis of cancer genomes, epigenomes, and transcriptomes. BMC Bioinformatics 9: 422.
35. Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357.
36. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
37. Chari R, Lonergan KM, Ng RT, MacAulay C, Lam WL, et al. (2007) Effect of active smoking on the human bronchial epithelium transcriptome. BMC Genomics 8: 297.
38. Babbage G, Ottensmeier CH, Blaydes J, Stevenson FK, Sahota SS (2006) Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res 66: 3996-4000.
39. Kimoto Y (1998) Expression of heavy-chain constant region of immunoglobulin and T-cell receptor gene transcripts in human non-hematopoietic tumor cell lines. Genes Chromosomes Cancer 22: 83-86.
40. Qiu X, Zhu X, Zhang L, Mao Y, Zhang J, et al. (2003) Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells. Cancer Res 63: 6488-6495.
41. Chen Z, Gu J (2007) Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J 21: 2931-2938.
42. Park KS, Wells JM, Zorn AM, Wert SE, Laubach VE, et al. (2006) Transdifferentiation of ciliated cells during repair of the respiratory epithelium. Am J Respir Cell Mol Biol 34: 151-157.
43. Bota S, Auliac JB, Paris C, Metayer J, Sesboue R, et al. (2001) Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy. Am J Respir Crit Care Med 164: 1688-1693.
44. Venmans BJ, van Boxem TJ, Smit EF, Postmus PE, Sutedja TG (2000) Outcome of bronchial carcinoma in situ. Chest 117: 1572-1576.
45. Marenholz I, Zirra M, Fischer DF, Backendorf C, Ziegler A, et al. (2001) Identification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA library. Genome Res 11: 341-355.
46. Marshall D, Hardman MJ, Nield KM, Byrne C (2001) Differentially expressed late constituents of the epidermal cornified envelope. Proc Natl Acad Sci U S A 98: 13031-13036.
47. Moffatt P, Salois P, St-Amant N, Gaumond MH, Lanctot C (2004) Identification of a conserved cluster of skin-specific genes encoding secreted proteins. Gene 334: 123-131.
48. Inada R, Matsuki M, Yamada K, Morishima Y, Shen SC, et al. (2000) Facilitated wound healing by activation of the Transglutaminase 1 gene. Am J Pathol 157: 1875-1882.
49. Nozaki I, Lunz JG 3rd, Specht S, Stolz DB, Taguchi K, et al. (2005) Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation. Lab Invest 85: 109-123.
50. Green KJ, Simpson CL (2007) Desmosomes: new perspectives on a classic. J Invest Dermatol 127: 2499-2515.
51. Li Q, Lu Q, Estepa G, Verma IM (2005) Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse. Proc Natl Acad Sci U S A 102: 15977-15982.
52. Eferl R, Hasselblatt P, Rath M, Popper H, Zenz R, et al. (2008) Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc Natl Acad Sci U S A 105: 10525-10530.
53. Moon JO, Welch TP, Gonzalez FJ, Copple BL (2009) Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol 296: G582-592.
54. Scharpfenecker M, Floot B, Russell NS, Ten Dijke P, Stewart FA (2009) Endoglin haploinsufficiency reduces radiation-induced fibrosis and telangiectasia formation in mouse kidneys. Radiother Oncol 92: 484-491.
55. Stawowy P, Margeta C, Kallisch H, Seidah NG, Chretien M, et al. (2004) Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase. Cardiovasc Res 63: 87-97.
56. Beyer C, Schett G, Gay S, Distler O, Distler JH (2009) Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis. Arthritis Res Ther 11: 220.
57. Higgins DF, Kimura K, Iwano M, Haase VH (2008) Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 7: 1128-1132.
58. Kimura K, Iwano M, Higgins DF, Yamaguchi Y, Nakatani K, et al. (2008) Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 295: F1023-1029.
59. Hayashi T, Yamashita C, Matsumoto C, Kwak CJ, Fujii K, et al. (2008) Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress. Am J Physiol Heart Circ Physiol 294: H2197-2203.
60. Murdoch CE, Zhang M, Cave AC, Shah AM (2006) NADPH oxidasedependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res 71: 208-215.
61. Dawn B, Bolli R (2005) HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection? Am J Physiol Heart Circ Physiol 289: H522-524.
62. Ryter SW, Choi AM (2002) Heme oxygenase-1: molecular mechanisms of gene expression in oxygen-related stress. Antioxid Redox Signal 4: 625-632
63. Chang JT, Nevins JR (2006) GATHER: a systems approach to interpreting genomic signatures. Bioinformatics 22: 2926-2933.
64. Yu X, Ng CP, Habacher H, Roy S (2008) Foxj1 transcription factors are master regulators of the motile ciliogenic program. Nat Genet 40: 1445-1453.
65. Ermakov A, Stevens JL, Whitehill E, Robson JE, Pieles G, et al. (2009) Mouse mutagenesis identifies novel roles for left-right patterning genes in pulmonary, craniofacial, ocular, and limb development. Dev Dyn 238: 581-594.
66. Wallingford JB (2006) Planar cell polarity, ciliogenesis and neural tube defects. Hum Mol Genet 15 Spec No 2: R227-234.
67. Knowles MR, Boucher RC (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109: 571-577.
68. Salonen EM, Vartio T, Hedman K, Vaheri A (1984) Binding of fibronectin by the acute phase reactant C-reactive protein. J Biol Chem 259: 1496-1501.
69. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, et al. (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134: 657-667.
70. Bazzi H, Fantauzzo KA, Richardson GD, Jahoda CA, Christiano AM (2007) Transcriptional profiling of developing mouse epidermis reveals novel patterns of coordinated gene expression. Dev Dyn 236: 961-970.
71. Matsui T, Hayashi-Kisumi F, Kinoshita Y, Katahira S, Morita K, et al. (2004) Identification of novel keratinocyte-secreted peptides dermokine-alpha/-beta and a new stratified epithelium-secreted protein gene complex on human chromosome 19q13.1. Genomics 84: 384-397.
72. Oomizu S, Sahuc F, Asahina K, Inamatsu M, Matsuzaki T, et al. (2000) Kdap, a novel gene associated with the stratification of the epithelium. Gene 256:19-27.
73. Tsuchida S, Bonkobara M, McMillan JR, Akiyama M, Yudate T, et al. (2004) Characterization of Kdap, a protein secreted by keratinocytes. J Invest Dermatol 122: 1225-1234.
74. Yagihara H, Kinjo E, Kobayashi Y, Tsuji A, Nishimura Y, et al. (2009) Expression of canine Kdap in normal, hyperplastic and neoplastic epidermis. Vet J 180: 348-355.
75. Kong W, Longaker MT, Lorenz HP (2003) Molecular cloning and expression of keratinocyte proline-rich protein, a novel squamous epithelial marker isolated during skin development. J Biol Chem 278: 22781-22786.
76. Lee WH, Jang S, Lee JS, Lee Y, Seo EY, et al. (2005) Molecular cloning and expression of human keratinocyte proline-rich protein (hKPRP), an epidermal marker isolated from calcium-induced differentiating keratinocytes. J Invest Dermatol 125: 995-1000.
77. Richardson RJ, Dixon J, Malhotra S, Hardman MJ, Knowles L, et al. (2006) Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch. Nat Genet 38: 1329-1334.
78. Florin L, Knebel J, Zigrino P, Vonderstrass B, Mauch C, et al. (2006) Delayed wound healing and epidermal hyperproliferation in mice lacking JunB in the skin. J Invest Dermatol 126: 902-911.
79. Zenz R, Wagner EF (2006) Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors. Int J Biochem Cell Biol 38: 1043-1049.
80. Paramio JM, Segrelles C, Ruiz S, Martin-Caballero J, Page A, et al. (2001) The ink4a/arf tumor suppressors cooperate with p21cip1/waf in the processes of mouse epidermal differentiation, senescence, and carcinogenesis. J Biol Chem 276: 44203-44211.
81. Vijayachandra K, Higgins W, Lee J, Glick A (2009) Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes. Mol Carcinog 48: 181-186.
82. Jie G, Zhixiang S, Lei S, Hesheng L, Xiaojun T (2007) Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer. Int J Clin Pract 61: 1523-1529.
83. Svensson S, Nilsson K, Ringberg A, Landberg G (2003) Invade or proliferate? Two contrasting events in malignant behavior governed by p16(INK4a) and an intact Rb pathway illustrated by a model system of basal cell carcinoma. Cancer Res 63: 1737-1742.
84. Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA (2003) Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies. Lung Cancer 41 Suppl 1: S29-42.
85. Capdevila J, Elez E, Macarulla T, Ramos FJ, Ruiz-Echarri M, et al. (2009) Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment. Cancer Treat Rev 35: 354-363.
86. Cascone T, Gridelli C, Ciardiello F (2007) Combined targeted therapies in non-small cell lung cancer: a winner strategy? Curr Opin Oncol 19: 98-102.
87. Reade CA, Ganti AK (2009) EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab. Biologics 3: 215-224.
88. Vokes EE, Chu E (2006) Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers. Oncology (Williston Park) 20:15-25.
89. Zang XP, Lerner M, Brackett D, Pento JT (2009) Influence of KGF on the progression of pancreatic cancer. Anticancer Res 29: 3417-3420.
90. Chang TS, Jeong W, Woo HA, Lee SM, Park S, et al. (2004) Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J Biol Chem 279: 50994-51001.
91. Singh A, Ling G, Suhasini AN, Zhang P, Yamamoto M, et al. (2009) Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med 46: 376-386.
92. Wei Q, Jiang H, Matthews CP, Colburn NH (2008) Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies. Proc Natl Acad Sci U S A 105: 19738-19743.
93. Martin HJ, Maser E (2009) Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes. Chem Biol Interact 178: 145-150.
94. Chanas SA, Jiang Q, McMahon M, McWalter GK, McLellan LI, et al. (2002) Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem J 365: 405-416.
95. Macleod AK, McMahon M, Plummer SM, Higgins LG, Penning TM, et al. (2009) Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 30: 1571-1580.
96. Singh A, Rangasamy T, Thimmulappa RK, Lee H, Osburn WO, et al. (2006) Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2. Am J Respir Cell Mol Biol 35: 639-650.
97. Taylor RC, Acquaah-Mensah G, Singhal M, Malhotra D, Biswal S (2008) Network inference algorithms elucidate Nrf2 regulation of mouse lung oxidative stress. PLoS Comput Biol 4: e1000166.
98. Quinn AM, Penning TM (2008) Comparisons of (+/2)-benzo[a]pyrene-trans-7, 8-dihydrodiol activation by human cytochrome P450 and aldo-keto reductase enzymes: effect of redox state and expression levels. Chem Res Toxicol 21: 1086-1094.
99. Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A, et al. (2005) Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin Cancer Res 11: 1776-1785.
100. Gao L, Mann GE (2009) Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 82: 9-20.
101. Lee SH, Seo GS, Park PH, Choi JY, Park YN, et al. (2003) Increased expression of O-acetyl disialoganglioside synthase during rat liver fibrogenesis relates to stellate cell activation. Biochem Biophys Res Commun 303: 954-961.
102. Kashima TG, Nishiyama T, Shimazu K, Shimazaki M, Kii I, et al. (2009) Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions. Hum Pathol 40: 226-237.
103. Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, et al. (2007) Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 101: 313-321.
104. Norris RA, Damon B, Mironov V, Kasyanov V, Ramamurthi A, et al. (2007) Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 101: 695-711.
105. Segade F, Trask BC, Broekelmann TJ, Pierce RA, Mecham RP (2002) Identification of a matrix-binding domain in MAGP1 and MAGP2 and intracellular localization of alternative splice forms. J Biol Chem 277: 11050-11057.
106. Trask BC, Trask TM, Broekelmann T, Mecham RP (2000) The microfibrillar proteins MAGP-1 and fibrillin-1 form a ternary complex with the chondroitin sulfate proteoglycan decorin. Mol Biol Cell 11: 1499-1507.
107. Argraves WS, Greene LM, Cooley MA, Gallagher WM (2003) Fibulins: physiological and disease perspectives. EMBO Rep 4: 1127-1131.
108. Kalamajski S, Oldberg A (2007) Fibromodulin binds collagen type I via Glu-353 and Lys-355 in leucine-rich repeat 11. J Biol Chem 282: 26740-26745.
109. Bao S, Ouyang G, Bai X, Huang Z, Ma C, et al. (2004) Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5: 329-339.
110. Fu Z, Wang M, Gucek M, Zhang J, Wu J, et al. (2009) Milk fat globule protein epidermal growth factor-8: a pivotal relay element within the angiotensin II and monocyte chemoattractant protein-1 signaling cascade mediating vascular smooth muscle cells invasion. Circ Res 104: 1337-1346.
111. Jinushi M, Nakazaki Y, Carrasco DR, Draganov D, Souders N, et al. (2008) Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment. Cancer Res 68: 8889-8898.
112. Miyamoto A, Lau R, Hein PW, Shipley JM, Weinmaster G (2006) Microfibrillar proteins MAGP-1 and MAGP-2 induce Notch1 extracellular domain dissociation and receptor activation. J Biol Chem 281: 10089-10097.
113. Ouyang G, Liu M, Ruan K, Song G, Mao Y, et al. (2009) Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway. Cancer Lett 281: 213-219.
114. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, et al. (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324: 1457-1461.
115. Olson P, Hanahan D (2009) Cancer. Breaching the cancer fortress. Science 324: 1400-1401.
116. Helleman J, Jansen MP, Span PN, van Staveren IL, Massuger LF, et al. (2006) Molecular profiling of platinum resistant ovarian cancer. Int J Cancer 118: 1963-1971.
117. Guarino M, Tosoni A, Nebuloni M (2009) Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Hum Pathol. 40: 1365-1376.
118. Apte MV, Wilson JS (2004) Mechanisms of pancreatic fibrosis. Dig Dis 22: 273-279.
119. Bachem MG, Zhou S, Buck K, Schneiderhan W, Siech M (2008) Pancreatic stellate cells-role in pancreas cancer. Langenbecks Arch Surg 393: 891-900.
120. Vonlaufen A, Joshi S, Qu C, Phillips PA, Xu Z, et al. (2008) Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res 68: 2085-2093.
121. Vonlaufen A, Phillips PA, Xu Z, Goldstein D, Pirola RC, et al. (2008) Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance. Cancer Res 68: 7707-7710.
122. Amann T, Bataille F, Spruss T, Muhlbauer M, Gabele E, et al. (2009) Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 100: 646-653.
123. Atzori L, Poli G, Perra A (2009) Hepatic stellate cell: a star cell in the liver. Int J Biochem Cell Biol 41: 1639-1642.
124. Wells RG (2008) Cellular sources of extracellular matrix in hepatic fibrosis. Clin Liver Dis 12: 759-768, viii.
125. Blaine SA, Ray KC, Branch KM, Robinson PS, Whitehead RH, et al. (2009) Epidermal growth factor receptor regulates pancreatic fibrosis. Am J Physiol Gastrointest Liver Physiol 297: G434-441.
126. Erkan M, Kleeff J, Gorbachevski A, Reiser C, Mitkus T, et al. (2007) Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 132: 1447-1464.
127. Yan W, Shao R (2006) Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J Biol Chem 281: 19700-19708.
128. Fraga CH, True LD, Kirk D (1998) Enhanced expression of the mesenchymal marker, vimentin, in hyperplastic versus normal human prostatic epithelium. J Urol 159: 270-274.
129. Franke WW, Grund C, Kuhn C, Jackson BW, Illmensee K (1982) Formation of cytoskeletal elements during mouse embryogenesis. III. Primary mesenchymal cells and the first appearance of vimentin filaments. Differentiation 23: 43-59.
130. Kuroishi S, Suda T, Fujisawa T, Ide K, Inui N, et al. (2009) Epithelialmesenchymal transition induced by transforming growth factor-beta1 in mouse tracheal epithelial cells. Respirology 14: 828-837.
131. Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39: 305-318.
132. Vermeer PD, Panko L, Karp P, Lee JH, Zabner J (2006) Differentiation of human airway epithelia is dependent on erbB2. Am J Physiol Lung Cell Mol Physiol 291: L175-180.
133. Hefler-Frischmuth K, Hefler LA, Heinze G, Paseka V, Grimm C, et al. (2009) Serum C-reactive protein in the differential diagnosis of ovarian masses. Eur J Obstet Gynecol Reprod Biol 147: 65-68.
134. Shih Ie M (2007) Application of human leukocyte antigen-G expression in the diagnosis of human cancer. Hum Immunol 68: 272-276.
135. Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, et al. (2008) C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 123: 1133-1140.
136. Yie SM, Yang H, Ye SR, Li K, Dong DD, et al. (2007) Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol 14: 2721-2729.
137. Yie SM, Yang H, Ye SR, Li K, Dong DD, et al. (2007) Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer 58: 267-274.
138. Yie SM, Yang H, Ye SR, Li K, Dong DD, et al. (2007) Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol 128: 1002-1009.
139. Yoneda K, Iida H, Endo H, Hosono K, Akiyama T, et al. (2009) Identification of Cystatin SN as a novel tumor marker for colorectal cancer. Int J Oncol 35:33-40.
140. Gresner P, Gromadzinska J, Wasowicz W (2007) Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 57: 1-25.
141. Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, et al. (2009) Role of Xenobiotic-Metabolizing Enzyme Gene Polymorphisms and Interactions with Environmental Factors in Susceptibility to Gastric Cancer in Kashmir Valley. J Gastrointest Cancer 40: 26-32.
142. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, et al. (2008) A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 29: 1164-1169.
143. Brodeur GM, Minturn JE, Ho R, Simpson AM, Iyer R, et al. (2009) Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res 15:3244-3250.
144. Cimmino F, Schulte JH, Zollo M, Koster J, Versteeg R, et al. (2009) Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness. Oncogene 28: 2015-2023.
145. Nakagawara A (2001) Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett 169: 107-114.
146. Qian J, Massion PP (2008) Role of chromosome 3q amplification in lung cancer. J Thorac Oncol 3: 212-215.
147. Garnis C, Lockwood WW, Vucic E, Ge Y, Girard L, et al. (2006) High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int J Cancer 118: 1556-1564.
148. Pei J, Balsara BR, Li W, Litwin S, Gabrielson E, et al. (2001) Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes Chromosomes Cancer 31: 282-287.
149. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, et al. (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41: 1238-1242.